A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer (Q39436586)

12 September 2017

title

A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer (English)

1 reference

12 September 2017

5

1 reference

12 September 2017

A Bonnomet

1

1 reference

12 September 2017

L Syne

2

1 reference

12 September 2017

A Brysse

3

1 reference

12 September 2017

E Feyereisen

4

1 reference

12 September 2017

A Noël

6

1 reference

12 September 2017

J-M Foidart

7

1 reference

12 September 2017

P Birembaut

8

1 reference

12 September 2017

M Polette

9

1 reference

12 September 2017

C Gilles

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

28 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

31

1 reference

12 September 2017

issue

33

1 reference

12 September 2017

page(s)

3741-3753

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.540

12 September 2017

exact match

0 references

cites work

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-to-mesenchymal transitions and circulating tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

The role of epithelial-mesenchymal transition in cancer pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

The basics of epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Circulating tumour cells in cancer patients: challenges and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Circulating tumor cells (CTC) detection: clinical impact and future directions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transitions in development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition and cell cooperativity in metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

The role of the ZEB family of transcription factors in development and disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.540

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.540

1 reference

12 September 2017

1 reference